1. Home
  2. CLW vs SLGL Comparison

CLW vs SLGL Comparison

Compare CLW & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearwater Paper Corporation

CLW

Clearwater Paper Corporation

HOLD

Current Price

$20.33

Market Cap

285.1M

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$68.43

Market Cap

254.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLW
SLGL
Founded
1926
1997
Country
United States
Israel
Employees
3710
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
285.1M
254.1M
IPO Year
2008
2016

Fundamental Metrics

Financial Performance
Metric
CLW
SLGL
Price
$20.33
$68.43
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$20.33
$110.00
AVG Volume (30 Days)
122.9K
56.4K
Earning Date
04-28-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,555,400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.16
$223.84
P/E Ratio
N/A
N/A
Revenue Growth
12.42
N/A
52 Week Low
$11.73
$23.15
52 Week High
$23.59
$97.97

Technical Indicators

Market Signals
Indicator
CLW
SLGL
Relative Strength Index (RSI) 47.70 37.83
Support Level $20.28 $64.78
Resistance Level $20.80 $80.66
Average True Range (ATR) 0.86 4.42
MACD -0.26 -0.93
Stochastic Oscillator 46.65 15.21

Price Performance

Historical Comparison
CLW
SLGL

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: